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During the last  two decades various methods of determining the 
power  of  human  sera  to  neutralize  poliomyelitis  virus  have  been 
employed,  and  from  them  various  clinical  and  epidemiologic con- 
clusions have  been drawn.  Few will  deny that  these studies have 
added to knowledge with regard to poliomyelitis but at the same time 
there is a  growing belief that from some of them, perhaps, attempts 
have been made to obtain more clinical and epidemiologic information 
than the methods afford.  For instance, although it is open to doubt 
whether the methods used to make these determinations in clinical 
poliomyelitis  are  very  accurate,  one  fact  is  becoming increasingly 
apparent;  namely,  that  in  neutralization  tests  with  poliomyelitis 
virus, different results may be obtained with some human sera when 
tested  with  different  strains  of  virus.  Thus  certain  convalescent 
sera tested with a strain which has been recently isolated from a human 
case will act differently than when tested with a strain which has been 
subjected to a long series of monkey passages.  It is our present pur- 
pose to report similar comparative tests on sera obtained from normal 
human adults who did not give a history of having sustained a recog- 
nizable  attack of poliomyelitis, and to  discuss them in  the light of 
previous  results  with  sera  from  convalescent  and  normal  persons 
representing younger age groups.  The purpose of such a  discussion 
mainly concerns the specificity of the antigen used in such neutraliza- 
tion tests on human sera.  In experimental work in this disease anti- 
* The expenses of this investigation have been defrayed by a grant from the 
National Research Council 
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viral properties appear in the blood of the convalescent or immunized 
monkey, and, more or less coincidently, the animal may be found to 
be  immune  to  a  subsequent  intracerebral  inoculation  of  the  virus. 
In human sera  (both convalescent and normal)  the presence of sub- 
stance which neutralizes poliomyelitis virus has, by analogy therefore, 
been taken as a  measure of "immunity," although it is recognized, of 
course, that the extent to which the mere presence of such neutraliz- 
ing antibodies represents immunity is a  matter of some speculation. 
But the difference between the situations in the monkey and in man is 
that in the monkey neutralization tests have usually been made with 
the  actual  strain  which  induced  the  experimental  disease,  whereas 
most human sera have been tested with strains of virus which may be 
quite  different  from  those  which  induce  the  human  disease.  As  a 
result it now seems questionable whether human immunity to polio- 
myelitis  has  been  very accurately  determined  by  the  methods  em- 
ployed in the past and it will be with this fact that this paper will be 
concerned. 
The early methods of performing virus neutralization tests in poliomyelitis, 
the results, and their interpretations will not be reviewed because the reader may 
be referred to a recent article by Wells (1) for a summary of these subjects.  In 
the majority of these and subsequent studies it was assumed that the presence in 
human blood of a  given amount of substance which  neutralized poliomyelitis 
virus was a reliable test for ;mmunity in this disease.  On this basis comparisons 
have been made between tests performed on sera from patients who had sustained 
frank attacks of poliomyelitis,  from contacts, and from individuals  who were not 
known to have been contacts or to have sustained a recognized attack of the disease. 
Interpretations have also been drawn from comparisons  made  between  tests on 
the sera of normal individuals  from this country as opposed to those from regions 
where clinical poliomyelitis is thought to be rare, such as:  Porto Rico (2), Liberia 
(3), Greenland (4), and certain parts of China (4, 5).  Similar interpretations have 
been drawn from the results of tests on normal individuals  from the northern as 
opposed to the southern part of this country (6) ; and on normal children and adults 
from rural districts as opposed to normal urban individuals of the same age groups 
(7,  8).  All of these tests were performed with strains of the virus which  had 
been passed through monkeys many times. 
Almost from the beginning of this work it became apparent that the average 
neutralizing power of sera from normal, adult individuals did not differ much from 
that of the sera of convalescents, most of those tested also being adults.  In corn- JOHN  R.  PAUL AND  JAMES D.  TRASK  449 
paring the two groups, Shaughnessy, Harmon, and Gordon (8) found that antiviral 
titres of individual  samples of normal sera appeared to be more potent in their 
action against the virus than were those of the sera of convalescents.  Brodle (9) 
found that in 70 per cent of his normal adult sera the neutralizing power was about 
four-fifths  that of pooled  convalescent  sera,  and in 30 per cent it was equal  in 
titre.  Subsequently Howitt (10) pointed out that the average power of individual 
samples of convalescent sera to neutralize poliomyelitis virus was perhaps less than 
had been generally supposed.  This fact becomes even more evident if one com- 
piles from the literature the available series of tests on individual samples of serum 
in which virus: serum mixtures have been set up in a dilution of 1:1, 1:2, or 1:3, 
and compares  the normal with the convalescent  results  according to age groups. 
In fact, with the exception of Aycock's convalescent  findings  (7)  (which are not 
included because they were based on pooled lots of sera), the average neutralizing 
power of individual  samples of convalescent  sera reported in the literature seems 
to be uniformly less in all age groups than that of normal sera.  The many observa- 
tions on this point will not be transcribed  in detail but general trends of the results 
by different  investigators are shown by the graphs in Fig.  1.  In this figure we 
have included only those series of tests which have been reported s'mce 1929.  Prior 
to that date the number of reported tests in different  age groups was small and 
certain variations in technique render a comparison with the recent work somewhat 
difficult.  There are still technical  differences which involve some of the results 
shown in Fig. 1, but only those tests have been included in which virus : undiluted 
serum mixtures have been set up in a proportion of 1:1, 1:2, or 1:3. 
With the results  expressed as they are in Fig.  1, and in so far as the data go, 
it will be seen that individuals  from rural districts have less than the normal, 
average amount of antiviral substance,  and that contacts appear to have a little 
above the average,  as do also  individuals  from regions  where  poliomyelitis  is 
thought to be rare.  There is no evidence that the acquisition of the clinical disease 
in the remote or recent past, gives rise to an increase in antiviral substance when 
tested  with  passage  strains,  although it  is  unfortunate  that  so  few  tests  are 
reported in the literature which have been done on convalescent sera from children. 
We shall review next the question of variation in the virus and the comparisons 
between  neutralization  tests performed with different strains.  That old passage 
strains of poliomyelitis virus may exhibit slight immunological differences, one from 
another, was described  in 1929 by Stewart and Rhoads (21).  That more easily 
demonstrable  differences existed between a strain recently isolated from a human 
ease,  and a  strain  which  had been passed  through monkeys many times  was 
observed in 1931 by Burner and Maenamara (22).  The principles of their obser- 
vation have subsequently  been confirmed (23, 24, 20, 25).  There is no evidence 
to show that all such recently isolated strains are alike, and the actual number of 
series of neutralization tests on human sera in which results  with several strains 
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to suggest that the situation shown in Fig. 1 would be altered if the tests had been 
done with so called "human" strains. I 
For instance,  in comparing  the neutralizing  action of different human sera on 
their Australian human strain and on a New York passage (M V) strain, Burner and 
Macuamara (22) found that although pooled, convalescent  sera would neutralize 
both strains,  a  few tests with individual  samples of convalescent  sera failed  to 
show this parallelism,  in that only the human strain was neutralized. 
Later Howitt (20) made similar, comparative observations upon seven samples 
of adult, convalescent  sera.  All of these  convalescent  sera neutralized  her 1931 
human strain,  whereas less than half of these sera neutralized  her passage  (M V) 
strain.  Howitt concluded that in judging the neutralizing  ability of human sera 
it would seem preferable  to employ a virus that had not undergone  too great a 
modification by repeated  transfer through monkeys.  It is worth noting that the 
conclusion was based on work with a human strain which was not derived from the 
epidemic in which Howitt's patients had sustained  their attacks of poliomyelitis. 
We (25) have also performed this type of experiment upon sera obtained from 
children in which tests with our human (W--7th passage)  strain were compared 
to those of a passage (M) strain.  The children tested were either normal, contacts, 
or in early or late convalescent  stages  of an abortive or frank  attack  of polio- 
myelitis.  Their exposure  to, or acquisition  of the disease occurred  in the same 
epidemic from which the human strain was isolated.  From the results,  and in 
spite of the present difficulties inherent  in the technique,  it has seemed that those 
tests performed with the human strain gave a better concept of antiviral properties 
induced by the human disease than did similar tests performed with the passage 
strain. 
It  has  been  our  object in  the  present  study  to  amplify the  pre- 
viously reported results by performing a comparative series of tests on 
samples of sera from normal adults using two human and two passage 
1 Hereafter the term human strain will be used  in this article  to designate  a 
strain recently isolated  from a  case of human poliomyelitis.  The terms human 
and passage  in referring  to strains of poliomyelitis virus have not been  defined. 
They are employed in this article because of priority of usage (23, 24).  Criticism 
might be raised against our use of the term human, in referring  later  to seventh 
and tenth passage strains.  As it is almost impossible at present  to perform neu- 
tralization  tests with strains  in their first few passages because of their low viru- 
lence for the monkey, the term human strain will be defined in this article as refer- 
ring to a strain which has not been passed many times beyond the point at which 
it  is  suitable  for use  in  neutralization  tests.  Passage  strains  represent  those 
strains  passed many times beyond this point.  Although both our human strains 
(W and F) came from the same epidemic, the W strain should perhaps be qualified 
by the terms,--1931, New Haven (seventh passage);  and the F strain as,--1931~ 
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strains  of  the  virus.  The  experiments  have  also  been  devised  to 
throw some light on the following questions:  (a)  To what extent do 
human  strains  act  llke  one  another  when  tested  by  this  method? 
(b)  To  what  extent  do  passage  strains  act  like  one  another  in  this 
respect?  (c)  What  is  the  power  of normal  adult  sera  to  neutralize 
human poliomyelitis virus?  (d)  To  what  extent  do  the  findings  in 
these  human  strain  experiments  alter  certain  concepts  with  regard 
to  clinical  aspects,  and to the epidemiology of poliomyelitis based on 
passage strain  neutralization  experiments? 
Methods 
Strains  Emplayed.--Four strains  of  poliomyelitis  virus  were  used.  They 
included two human strains,  designated as W  and F; and two passage strains, 
designated as Aycock and M. 
Human Strains 
W Strain, New Haven, 1931.--0ur W strain was in its seventh passage.  Ob- 
tained in 1931 from the throat of a child  in the 1st day of an abortive attack of 
poliomyelitis, its isolation (26) and its first seven monkey passages (25) have been 
described.  Material  employed for all  neutralization  tests  came from a  single 
animal (Monkey B-6); a procedure which was followed in previous neutralization 
tests described with this strain.  *  The superuatant fluid  (after centrifugalization) 
from a 10 per cent suspension of ground cord, when mixed with an equal part of 
normal monkey serum and injected intracerebrally in 0.5 cc. amounts, has infected 
nine fresh monkeys thus tested.  The experimental disease so produced is clear-cut 
but usually not fatal.  In nine monkeys so infected, the incubation period to the 
onset of fever averaged about 6 days; the febrile period prior to the onset of paraly- 
sis about 4 days; and the mortality in this series of monkeys was about 12 per cent. 
F Strain, New York, 1931.mThis was obtained through the kindness of Dr. 
Simon Flexner of The Rockefeller Institute for Medical Research.  It had been 
isolated during the summer of 1931 from the medulla and spinal cord of a fatal 
ease of poliomyelitis and the sample we received represented the eighth passage. 
A virulence titration at this time showed that 0.5 ce. of a  1 per cent suspension 
of this material would infect a monkey but the experimental disease so produced 
was mild, whereas when a  similar amount of a  5 or 10 per  cent suspension was 
injected it was  severe. 
Material from a single animal (No. 1-97) representing the tenth passage was 
2 Monkey B-6 had contracted a severe form of the experimental disease.  For 
passing human strains it is our practice to select those animals which are most 
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eventually employed for all neutralization  tests,  using the same dosage as that of 
the W strain,  i.e., a 10 per cent cord suspension mixed with one part of undiluted 
serum.  The F strain was much more virulent for the monkey than our W strain. 
When mixed with normal monkey serum and inoculated  in 0.5 cc. amounts into 
two monkeys  the average incubation period was 3 ½  days, the febrile period of 2 ½  days, 
and the mortality 100 per cent.  All of the monkeys which were infected during 
the course of the neutralization  experiments were extensively paralyzed. 
Passage Strains 
Aycock Strain.--This was obtained through the kindness of Dr. W. L. Aycock 
of the Department of Preventive Medicine and Hygiene,  The Harvard Medical 
School.  It is a highly virulent strain for the monkey.  It had been used in several 
of the investigations  (4, 6, 7, 8, 11,  12,  14,  15,  19) referred  to in an earlier sec- 
tion of this paper.  The number of monkey passages  to which it has been sub- 
Fro. 1.  The per cent of normal,  convalescent,  and exposed individuals  whose 
sera neutralized  passage strains  of poliomyelitis virus,  arranged according  to age 
groups.  Data included  in  this  figure have been  obtained from reports  (2-20). 
In several of them (see B~liography) the published data have been supplemented 
by a personal  letter from one of the authors in which the ages of the individuals 
tested  and other details,  not appearing  in the text,  have been  kindly supplied. 
Included are  the  results  of  tests  performed  on individuals  from: (a)  rural 
districts  in this country (shown as small triangles)  and from: (b) regions where 
clinical poliomyelitis  is  thought to be rare  (shown as small  squares).  Normal 
represents  those individuals  from this country, England, and France in whom 
the environment  was not specified as rural.  Convalescents represent  individuals 
who in the great majority of instances  sustained  attacks of poliomyelitis accom- 
panied  by residual  paralysis.  No attempt  has been made to separate the con- 
valescent  cases into groups depending upon the interval from the time at which 
they sustained  an attack of paralysis  and the time when the blood sample  was 
obtained.  In those series in which this interval was stated it averaged  about 3 
or 4 years.  Only those individuals  have been  designated  as contacts who had 
recently (within a few months) been exposed to the disease.  The lines which have 
been drawn through the chart to represent the trends in which positive neutraliza- 
tion tests occurred in normal and convalescent  persons,  do not include  Groups 
a and b. 
Most of the points on the chart have been derived from groups of from 5 to 10 
tests performed  by a given investigator.  A few (three  convalescents)  represent 
the results  of single tests.  Obviously,  the result  of a  single test should  not be 
charted on a percentage  basis.  They have only been included to aid in the con- 
struction of the graph in those  age groups  in which data on convalescents  are 
scanty. 454  NEUTRALIZATION TEST  IN  POLIOMYELITIS 
jected is unknown.  After one passage just prior to its use in our experiments 
(Nov., 1933), a titration of the material showed that 0.5 cc. of a 0.01 per cent sus- 
pension would infect a  monkey (a smaller dose was not tried).  Material from a 
single animal (No.  1-74)  was used for all neutralization tests.  The dosage em- 
ployed was a  1 per cent cord suspension mixed with one part of undiluted serum. 
When this dose was mixed with an equal part of normal monkey serum and inocu- 
lated intracerebrally  in 0.5 cc. amounts into three monkeys the average incubation 
period was 4 days, the febrile period 1½ days, and all three of the monkeys died, 
as did all other monkeys which contracted the experimental disease in the course 
of the neutralization tests with this strain. 
M  Slrain.--This highly virulent strain was obtained through the kindness of 
Drs. W. H. Park and E. R. Weyer from the Bureau of Laboratories, Department 
of Health, City of New York.  It is a mixed strain and so its origin, or the number 
of  monkey  passages  to  which  it  had  been  subjected,  is  unknown.  Since  we 
received it in September, 193i, it has had two further passages.  Material for all 
neutralization tests came from a  single animal  (No.  1-49) and was prepared as a 
0.2 per cent suspension, which was mixed with one part of normal monkey serum 
and  injected intracerebrally in  0.5  cc.  amounts.  The  experimental disease in 
nine monkeys showed an average incubation period of 5 days, a febrile period of 2 
days, and a mortality of 100 per cent. 
Technique of Neutralization Tests.--This will not be described in detail because 
the methods employed have been given in a  previous publication (25).  It may 
suffice to say that the four strains were employed in the dosages mentioned above, 
and were mixed with an equal part of undiluted serum in all of our experiments 
reported in this paper.  This mixture was placed in the incubator for 2 hours and 
monkeys were inoculated intracerebrally in 0.5 cc. amounts.  Daily temperature 
readings were taken over a  period of 4 weeks, on all animals thus inoculated.  If 
any  animal died within  this period from  some cause other  than  experimental 
poliomyelitis the test was repeated.  In the course of the 126 neutralization tests 
performed in this  series of  experiments,  three such  animals died during  the  4 
week period of observation; two from dysentery, and one from a  brain abscess. 
Individual monkeys were used one to eight times in the course of these experiments 
which were carried out over a period of a year. 
In all experiments in which the neutralizing power of individual samples of 
human sera were tested, two control tests were employed; a  protected control,-- 
in which pooled convalescent serum was mixed with the  virus,-- and  an  unpro- 
tected  control,--in which  normal  monkey serum was mixed with the virus.  If 
unexplained results occurred in the controls the experiment was discarded.  A 
result of this type occurred once in fourteen experiments.  It was an experiment 
in which the W  strain was used, and the protected control developed the experi- 
mental disease after a long incubation period.  In another experiment, in which 
the M strain was used, the unprotected control failed to develop the experimental JOHN  R.  PAUL  AND  JAMES  D.  TRASK  455 
disease  but  this  monkey, which  was used  through an  error,  was subsequently 
shown to be resistant  to a  larger dose of this virus. 3 
The results of these tests have been expressed only in terms of a  1:1 serum: 
virus mixture.  A plus sign signifies  that neutralizing properties were present in 
the serum, in that the animal did not develop the experimental disease within the 
4 week period of observation; a  minus sign signifies  that neutralizing properties 
were absent, in that the animal developed the experimental disease within a  few 
days of the incubation period  (to the onset of fever) shown by the unprotected 
control; and a plus-minus sign signifies so called partial neutralization, in that the 
incubation period  was prolonged for a  period  of 6  or more days beyond that 
exhibited by the unprotected control, the longest incubation period noted in all 
of the experiments being 28 days.  A questionable plus sign indicates that three 
tests were performed and that plus represents the majority result, but that dis- 
crepancies occurred in one of the three tests.  Protocols of our experiments appear 
at  the end of the paper  (Table  II).  Here it  will  be seen  that  thirteen  of the 
passage strain tests were repeated in satisfactory experiments either one or two 
times.  In sixteen  repetitive  tests  discrepancies  were encountered  twice  (4-  as 
opposed to +  once, and  -  as opposed to 4- once). 
By comparing the results  of repetitive  tests  with  those previously reported 
(25)  we find that discrepancies have been noted with the W  strain in about  11 
per cent of eighteen tests, and with passage strains in about 8 per cent of twenty- 
five  tests.  These  experiences  are  mentioned  to  emphasize  that  in  our hands 
unknown factors of error in the use of this test are not uncommon, and they reflect 
to some extent the experience of others (7), 
One criticism of the technique of our comparative tests is that different dos- 
ages were used for the human strains than were used for the passage strain experi- 
ments.  Owing  to  differences  in  virulence  for  the  monkey exhibited  by  these 
strains  this has proved a  variable which we could not overcome.  However, in 
comparing the human and passage strain tests described in this paper with those 
s In order to conserve monkeys in the passage strain experiments we frequently 
used as the unprotected control a monkey which had recovered from a  W  strain 
infection.  In a previous communication (25)  we found that, provided 10 weeks 
or more had elapsed between the two inoculations, an antecedent infection by the 
W  strain did not protect against an intracerebral inoculation of the M  strain in 
the dose used for the neutralization tests.  Reinfection occurred in the six instances 
in which the experiment was tried.  A  smaller number of experiments has also 
shown that the Aycock strain will also reinfect.  Previously infected monkeys of 
this type were therefore used not only as unprotected controls, but also as checks 
on some of the passage strain  neutralization  tests  (see  protocols in  Table II). 
The results of these check tests were only accepted if the monkey subsequently 
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which we have previously reported (25) we can find no evidence to show that this 
variable influences the results in any particular direction. 
Sera Employed.--Fourteen samples of normal adult  sera obtained from indi- 
viduals ranging from 21 to 45 years of age, who did not give a history of having 
had a recognized attack of poliomyelitis, were used in the course of these experi- 
ments.  These samples were collected in New Haven during the summer of I931 
when poliomyelitis was epidemic in that city.  4  One specimen was obtained from 
a  physician who had been exposed to poliomyelitis in the course of his hospital 
duties; the others were from individuals who offered their blood for therapeutic 
purposes to a member of their family ill with the disease.  Two samples of con- 
valescent sera obtained from adults who had sustained attacks  of poliomyelitis 
in childhood, were included as controls in this series.  Serum or blood from all 
of these individuals had been used for therapeutic purposes in 1931, and, as some 
of the patients so treated had apparently done well and others had done badly it 
was one of  our original objects to attempt to correlate the supposed therapeutic 
efficacy of the serum or blood with the results of the neutralization  tests.  The 
outcome of the tests was such that no such correlation could be made. 
Although collected during the summer of 1931 and subsequently kept in the 
ice box, these sera were not tested until 20 to 32 months had elapsed.  It is pos- 
sible that  the neutralizing power of some might have deteriorated  between  the 
20th and 32nd month hut no evidence of this supposition was apparent in the course 
of  the  experiments.  The majority of tests  with the  passage  strains  were per- 
formed between the 28th and 32nd month.  Inasmuch as none of the sera failed 
to neutralize  completely the passage strains of virus,  which  were the last  tests 
performed, there was no evidence that this particular neutralizing property had 
been lost by deterioration through aging. 
RESULTS 
The  results  of  our  series  of  neutralization  tests  made  with  four 
different  strains  of poliomyelitis virus  on fourteen  samples  of normal 
(or  contact)  adult  sera  and  two  adult  convalescent  sera  appear  in 
Table I.  Comparisons between the different strains may be expressed 
on  a  percentage  basis  if we  assume  that  when  partial  neutralization 
is observed with one strain,  and either no neutralization  or complete 
neutralization  with another,  a  50 per  cent agreement  exists;  or,  that 
when  questionably positive neutralization  is observed with one strain 
4 Criticism may be applied to the term normal in referring to these individuals. 
Some of them were intimate  contacts.  The difficulty of defining the degree of 
contact in this group was such, however, that  it has seemed more practical to 
consider them all as normal, particularly as we do not believe that the differentia- 
tion is pertinent to the problem under investigation. JOHN  R. PAUL  AND  JAMES  D. TRASK  457 
and positive with another, a  75 per cent agreement exists.  On this 
basis the agreement between the tests with the two human as opposed 
to the two passage strains might be roughly placed at 75 per cent.  On 
the same basis there is an 86  per  cent agreement between the two 
human strains, and a 92 per cent agreement between the two passage 
TABLE  I 
Neutralization of Normal Adult Sera by Two Human 
of Poliomyelitis Virus 
and  Two Passage Strains 
Subject  Type of  individual 
R.  Hn.  Convalescent 
D. Be. 
Epn.  Normal 
D. Bls. 
Chn.  " 
J. Dn. 
Sdb.  " 
Ytg.  " 
Klk.  " 
Msn. 
Cls.  " 
Wnr. 
Brn. 
Dvl.  " 
Ttr.  " 
Cpn. 
Age 
Human strains 
W  F 
~$. 
25  + 
27  0 
21 
26 
29 
30 
30 
30 
34 
35 
38 
38 
40 
43 
43 
45 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Passage  strains 
Aycock  M 
÷  + 
+  + 
o 
+  +* 
+  +2 (~) 
+  + 
+*  +* 
+*  +* 
+*  +* 
+  +* 
+  + 
+*  +* 
+  + 
+  +? (b) 
+  +* 
+, neutralization; +, partial neutralization; -,  no 
done (insufficient serum). 
+?  (a), three tests performed; one  -,  two  4.. 
-4-? (b), three tests performed; one ±, two  +. 
* Test repeated, result confirmed. 
neutralization; O, test not 
strains.  The last difference does not appear to be significant if one 
takes into account the experimental error of the method which we 
would place at about  10 per cent.  It will be seen, however, that in 
general these normal adult sera showed less power to neutralize human 
than passage strains.  Thus the percentage of positive neutralization ÷ 
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tests noted with the W  strain was 71; with the F  strain 71, with the 
Aycock strain  95,  and with the M  strain  92. 
Our  previously  reported  comparative  results  were  performed on 
sera from normal children, or children who were in early, late, or con- 
valescent  stages  of  abortive  or  frank  attacks  of  poliomyelitis.  In 
this younger group, which was largely composed of recent convales- 
cents, not only was there less agreement in the results obtained with 
the two strains than in the normal adults,  but the character of dis- 
agreement was generally in the opposite direction; namely, a  higher 
percentage  of  positive  neutralization  tests  was  obtained  with  the 
human strain. 
The sum total of our results on different types of sera can perhaps 
be best expressed in terms of graphs which appear in Fig. 2.  These 
have been devised along the same lines  as  those in  Fig. 1.  Here it 
becomes  apparent  that  in  our  passage  strain  experiments  there  is 
little evidence that the acquisition of either frank or abortive polio- 
myelitis has any influence upon the results of the tests, and by com- 
paring the right half of Fig. 2 with  Fig.  1, it  will be  noted that  our 
experience with this  passage  strain  has,  in  general,  been similar to 
those of others with passage strains.  With the human strain there is 
closer agreement with events which one might predict on the basis of 
analogy with other virus diseases; or in other words, in childhood at 
least, the acquisition of the clinical disease tends to elevate the "anti- 
human"  viral  properties  in  the  blood,  although  this  elevation may 
not be permanent.  ~ 
COMMENT 
In reviewing our results it should again be pointed out, as has been 
done in a previous article (25) that many factors are unknown regard- 
ing the neutralization  test in poliomyelitis.  These include:  (a)  the 
extent to  which a  positive  test  signifies immunity;  (b)  the  time of 
5  We found in previous work (25) that in testing convalescent sera from mild 
abortive attacks of poliomyelitis  the elevation of "anti-human" viral substance in 
the blood was occasionally transient.  Thus an increase in antiviral  substance, 
demonstrated in two patients in the (3 week) convalescent  sample, was not demon- 
strated in a later (14 month) sample.  This transient increase was not noted in 
several paralytic convalescents  similarly tested. TABI3 
Protocols of Neutra, 
Human strains 
~train.. 
Date of experiment  ............  May 17,1933 ] 
Control  Human 
sera  convales- 
cent 
Normal 
monkey 
Normal  Brn. 
human  Epn. 
sera  Klk. 
D.  Bls. 
Msn. 
Ptg. 
Cpn. 
Chn. 
Cls. 
Dvl. 
J. Dn. 
Sdb. 
Ttr. 
Wnr ° 
Convales-  R. I-In. 
cent sera  D. Be. 
days 
I  1-39  I+  1-66 
1-52  5 
B-19  + 
1-60  + 
1-44  6  -- 
1-45  5  -- 
1-48 
1-47  7 
-  1-75 
W--1931, New Haven 
Sept. 21, 1933 
F--1931, New York 
Jan. 30, 1934  Feb. 27, 19341  Apr. 23, 1934  Nov, 28, 1933 
days  day~  daya  days  days 
12  4-  1-94  +  1-83  +  1-88  +  1-71  + 
5  -  1-90  7  --1-84  5  -1-87  5  -  1-62t !  3  -- 
1-86  8  --  1-40!  + 
2-11  +  1-441  16  4- 
2-03  10  --  1-45!  + 
2-04  4  -- 
+  1-94 
-  1-83 
1-71  +  1-83  +J 1-86  + 
1-72  9  --  1-84  +  1-85  + 
1-73  +  1-85  +1-88  + 
1-74  +  1-86  +  1-87  + 
1-76  10  -  1-87  +  1-91  +i 
1-77  +  1-88  +  1-92  +] 
1-78  5  -  1-89  6  --1-93  6  - 
1° I 
B-19 
1-93  + 
+  1-91 !  + 
+  1-92  + 
Experiment dis- 
carded be- 
cause  of  re- 
sult  in  pro- 
tected control 
1-94  + 
1-91 
2-02 
1+ 
Died 
from 
abscess 
+  1-67§  Jr 
+  1-61t  + 
Preliminary  ex- 
periment  on 
previously in- 
fected mon- 
keys 
+,  protection;  ~,  partial protection;  -,  no protection.  * Incubation period in days to the onset 
t  Monkey  previously  infected  with  W  strain,  but susceptible to passage strain.  ~ Monkey previ¢ 
§  Monkey  previously infected with W  strain,  subsequently resistant to passage  strain. 
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ization Experiments 
Passage straln~ 
Aycock  I  M 
Mar. 25, 1934  May 12, 1934  [ Oct. 25, 1933 [_Jan. 9, 1934  [  Feb. 6, 1934 
d~s 
!-02 
"  I  1  ~'' 
+  2-10  +ll-71  l  I 
Mar. 6, 1934  ~ Apr. $, 1934  [ May 23, 1934 
~.~  ~.~  ~.~  ~  ~  ~'~ 
days  days  dayz  da~  days 
t-711  112-001+  I  q-  l:l-71  I  I1+  t-96  I  I1+  2-111  Iq- 
1-401  4  --  2-00  5 
1-59~ 
1-67§ 
2-08 
2-03 
2-04 
1-83 
1-94 
1-86 
1-88 
1-85 
1-92 
1-87 
-91 
2-07 
Insuf- 
fldent 
serum 
2-05 
2-06 
+ 
+ 
+ 
+ 
+ 
+ 
Died, dys- 1-95 
entery 
"  "  1-96 
÷ 
+ 
L-73 
1-4ot 
1-441 
1-45t 
1-59t 
1-62t 
1-61t 
8-11  [4  l-ll-59TI  [  +  11-6111  6 
++il 
1-4ot 
1-76t 
145t  111 i 
-I- 1-95  -/-  [I-96 
q- i  1-96  q-  1-95 
1-98  8  --12-00 
1-61tl  l-HI-99  I 28  [ -4- 
Z-09 12 
L-45t  6 
t-59~ 
~+ 
2-05 
+  z-06 
2-08 
1-71 
1-95 
2-10 
--  1-71  4 
--  1-76  5 
Jr  1-89  5 
1-94 
1-83 
1-88 
1-91 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Preliminary  experi-  ] Immune mon- 
merits  on  previ-  [  key used 
ously  infected  (through 
monkeys  error) as 
unprotected 
[  control 
af fever. 
ausly infected with W  strain, L~ter infected with M  strain,  subsequently  resistant  to passage strains. 
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appearance and duration of neutralizing antibodies in the blood after 
an  individual  has  sustained  an  attack  of  the  disease;  and  (c)  the 
specificity of antiviral substance detected by this method.  Further- 
more,  methods  of  performing  neutralization  tests  in  poliomyelitis 
are not very accurate, and perhaps this criticism can be more justly 
applied to human than to passage strain experiments.  The expense 
involved,  which precludes the performance of large numbers of re- 
petitive tests, and the differences in resistance to infection exhibited 
by different monkeys, tend to vitiate the results obtained.  From the 
character of the  methods employed, therefore, all  one can  perhaps 
learn are certain trends or directions in which the results seem to fall. 
The  interpretation  of  these  trends  or  the  clinical  or  epidemiologic 
significance of an experiment of this type is dependent, of course, upon 
the nature of the differences between different types of poliomyelitis 
virus.  This unfortunately is unknown.  The implication is, perhaps, 
that the difference between human and passage strains is comparable 
to the difference between the street virus as opposed to the fixed virus 
of rabies; or between yellow fever virus recently isolated from a human 
case by monkey inoculation as opposed to yellow fever virus which has 
been adapted to infect mice.  However, as far as poliomyelitis virus 
is  concerned, sufficient data do not exist on which to  base  such an 
analogy.  There is no evidence that all human strains of poliomyelitis 
virus are alike.  There is no evidence that the strains which we and 
others  have  designated  as  human  would  necessarily  acquire  the 
properties of passage strains if they were carried further through five, 
ten, or twenty monkeys.  These and other features go to show that 
the significance of human versus  passage strain  experiments in polio- 
myelitis is  unknown and that  such experiments should be taken at 
face value and do not warrant wide interpretations. 
SUMM ~RY 
In experiments devised to compare the neutralizing action of normal 
adult human sera on different strains of poliomyelitis virus, and to fill 
in  certain  gaps  in  our  series  of  neutralization  tests  with  different 
strains of virus on different types of cases in different age groups, we 
have made the following observations. 
1.  The difference between two human and two passage  strains of JOHN R.  PAUL AND JAMES D.  TRASK  463 
the virus when tested by this method amounted to about 25 per cent, 
and there was less power in normal adult sera to neutralize human 
than passage strains of virus. 
2.  The differences between the two human strains amounted to 15 
per cent, and between the two passage strains to 8 per cent, the last 
figure falling within the limits of the experimental error of the method. 
The  extent  to  which these  findings  affect certain  concepts  with 
regard to the epidemiology of poliomyelitis based on passage strain 
neutralization experiments cannot be determined from the data pre- 
sented in this paper, except that they more or less confirm the view 
previously derived from passage strain experiments, that 70 to 95 per 
cent of normal urban adults possess in their blood, substance which 
neutralizes poliomyelitis virus in a given amount.  However, certain 
other indications appear when the present results are supplemented by 
those we have previously obtained  (25).  Primarily, we have found 
no relation between the clinical acquisition of poliomyelitis and the 
presence of substance in the serum which neutralizes a passage strain 
of poliomyelitis virus.  With a passage strain the results seem rather 
to bear a  closer relationship to age than to illness.  With a  human 
strain we have obtained results in which there is some evidence, shown 
only in the juvenile group,  that acquisition of the clinical disease is 
accompanied by the appearance of antiviral properties in the blood. 
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